UNICYCIVE IS UNIFIED

We are a community of collaborators who thrive on connections and camaraderie. Currently, we are focused on developing new treatment options for patients with renal diseases, as kidney disease remains a major global health concern.

Why Dr. Glenn Chertow believes in Unicycive

A renowned nephrology expert, discusses the pioneering work of Unicycive Therapeutics in the treatment of kidney disease. Dr. Chertow offers a unique perspective on the promising future of kidney disease therapy, and Unicycive’s ability to make a meaningful impact in patients’ lives.

Kidney disease affects 15% of the U.S. adult population
1/3 Americans at risk of Chronic Kidney Disease
1 in 5 adults with diabetes, 1 in 5 adults with high blood pressure may have chronic kidney disease.
May have chronic kidney disease
350,000 Americans undergo kidney dialysis each year
Kidney disease affects 15% of the U.S. adult population
100,000 people in the U.S. are waiting for a kidney transplant